NEUTROPHIL-TO-LYMPHOCYTE RATIO AS AN INFECTIOUS COMPLICATIONS BIOMARKER IN COLORECTAL SURGERY (own data, systematic review and meta-analysis)
https://doi.org/10.33878/2073-7556-2020-19-4-71-92
Abstract
BACKGROUND: biological markers of inflammation belong to the main tool for predicting the risk of infectious complications at the preclinical stage. One of such biomarkers is the neutrophil-to-lymphocyte ratio (NLR), but an insufficient number of studies does not allow us to estimate its value as a predictor of infectious complications in colorectal surgery.
AIM: to determine the predictive value of NLR as a predictor of infectious complications after colorectal surgery.
PATIENTS AND METHODS: from January 2018 to December 2019 192 patients after colorectal surgery were included in the study. The rate of infectious complications, NLR levels differences in patients with and without infectious complications were determined, the area under the curve (AUC), sensitivity, specificity, negative and positive prognostic value of NLR on the 3rd (POD) and the 6th (POD) postoperative days were assessed. A literature search and meta-analysis of the data in accordance with the preferred reporting items for systematic reviews and meta-analyses checklist (PRISMA) were conducted. The information was taken from the Medline electronic database and the E-library, scientific electronic library, among the English and Russian literature without publication date restrictions by the keywords: “neutrophil/lymphocyteratio”, “neutrophil-to-lymphocyte ratio”, “neutrophil lymphocyte ratio”, “neutrophil ratio”, “lymphocyte ratio”, “colorectal”, “colon”, “rectum”.
The systematic review included all the studies related to assessing the prognostic value of NLR as a predictor of infectious complications in colorectal surgery.
RESULTS: infectious complications were detected in 29 (15.1%) of 192 patients. On the 3rd and the 6th POD, the patients with infectious complications had higher median NLR values than the patients without complications (p=0.0017 for the 3rd POD; p=0.018 for the 6th POD).
On the 3rd POD, the area under the curve at the NLR cut-off point 5.13 was 0.644, sensitivity – 69.7%, specificity – 60.7% (p=0.019). On the 6th POD, similar indicators at an NLR cut-off point of 3.94 were 0.75, 75.9% and 70.6%, respectively (p<0,001). Four studies, which included 1,152 observations, were added in the meta-analysis. On the 3th POD, the summarized AUC was 0.671, sensitivity – 86.3%, specificity – 60.3%
(p=0.014). The risk of infection with a biomarker above the threshold increased by more than 10 times (OR=10.2; 95% CI: 1.4-72). On the 4th POD, the above indicators were 0.711, 75.4%, 87.5%, respectively (p=0.002). Odds ratio was 51 (95% CI: 20-128).
CONCLUSION: the neutrophil-to-lymphocyte ratio is a reliable indicator for predicting the risk of developing infectious complications in colorectal surgery. In addition, the low values of this biomarker are an important criterion for the safe discharge of patients from hospital. The prevalence and availability of this test makes it easily feasible in clinical practice.
About the Authors
Yu. A. ShelyginRussian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
M. A. Sukhina
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
E. N. Nabiev
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
A. A. Ponomarenko
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
M. A. Nagudov
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
A. I. Moskalev
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
O. I. Sushkov
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
S. I. Achkasov
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia
References
1. Tiernan J, Cook A, Geh I, George B, Magill L, Northover J, et al. Use of a modified Delphi approach to develop research priorities for the association of coloproctology of Great Britain and Ireland. Color Dis. 2014;16(12):965–970. DOI: 10.1111/codi.12790
2. Shelygin Yu.A., Nagudov M.A., Ponomarenko A.A., Rybakov E.G. Oral antibiotic prophylaxis in colorectal surgery (systematic review and network meta-analysis). Koloproktologiya. 2018; no.3, pp.103–114. (In Russ.). DOI:10.33878/2073 7556 2018 0 3 103-114
3. Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH. Infectious Postoperative Complications Decrease Long-term Survival in Patients Undergoing Curative Surgery for Colorectal Cancer. Ann Surg. 2015;261(3):497–505. DOI: 10.1097/SLA.0000000000000854
4. McMillan DC, McArdle CS, Morrison DS. A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer. BJS. 2010;103(7):970–974. DOI: 10.1038/sj.bjc.6605864
5. Povsic MK, Beovic B, Ihan A. Perioperative increase in neutrophil CD64 expression is an indicator for intra-abdominal infection after colorectal cancer surgery. Radiol Oncol. 2017;51(2):211–220. DOI:10.1515/raon-2016-0016
6. Zoucas E, Lydrup M-L. Hospital costs associated with surgical morbidity after elective colorectal procedures: a retrospective observational cohort study in 530 patients. Patient Saf Surg. 2014;8(1):2–9. DOI:10.1186/1754-9493-8-2
7. Achkasov S.I., Surovegin E.S., Sushkov O.I., Lukashevych I.V., Savushkin A.V. Results of the implementation of the enhanced recovery program in coloproctology. Koloproktologia. 2018; no.2, pp.32-38. (In Russ.). DOI:10.33878/2073-7556-2018-0-2-32-38
8. Hewitt DB, Tannouri SS, Burkhart RA, Altmark R, Goldstein SD, Isenberg GA, et al. Reducing colorectal surgical site infections: a novel, resident-driven, quality initiative. Am J Surg. 2017;213(1):36–42. DOI:10.1016/j.amjsurg.2016.04.009
9. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med. 2000;28(8):2793–8. DOI: 10.1097/00003246-200008000-00019
10. Dovšak T, Ihan A, Didanovič V, Kansky A, Verdenik M, Hren NI. Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer. BMC Cancer. 18(1):235. DOI: 10.1186/s12885-018-4136-9
11. Galizia G, Lieto E, Zamboli A, De Vita F, Castellano P, Romano C, et al. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis. Surg (United States). 2015;158(1):112–20. DOI:10.1016/j.surg.2015.02.006
12. Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis. 2010;25(12):1427–1433. DOI:10.1007/s00384-010-1052-0
13. Ashizawa N, Furuya S, Katsutoshi S, Sudo M, Akaike H, Hosomura N, et al. Clinical significance of dynamic neutrophil-lymphocyte ratio changes in patients with colorectal cancer. Anticancer Res. 2020;40(4):2311–2317. DOI:10.21873/anticanres.14197
14. Absenger G, Szkandera J, Pichler M, Stotz M, Arminger F, Weissmueller M, et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer. 2013;109(2):395–400. DOI:10.1038/bjc.2013.346
15. Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ. Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg. 2007;5(1):27–30. DOI:10.1016/j.ijsu.2006.05.013
16. Benlice C, Onder A, Babazade R, Hrabe J, Stocchi L, Steele S, et al. Is the Neutrophil-to-Lymphocyte Ratio Associated With Increased Morbidity After Colorectal Surgery? Surg Laparosc Endosc Percutaneous Tech. 2019;29(1):36–39. DOI:10.1097/SLE.0000000000000588
17. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. DOI:0.1016/j.ajic.2008.03.002
18. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700 DOI:10.1136/bmj.b2700
19. Shelygin Yu.A., Tarasov M.A., Zarodnyuk I.V., Nagudov M.A., Alekseev M.V., Rybakov E.G. the role of neutrophil-to-lymphocyte ratio (NLR) in the diagnosis of low colorectal anastomosis leakage. Koloproktologia. 2017; no.4, pp.74-81. (In Russ.). DOI:10.33878/2073-7556-2017-0-4-74-81
20. Mik M, Dziki L, Berut M, Trzcinski R, Dziki A. Neutrophil to Lymphocyte Ratio and C-Reactive Protein as Two Predictive Tools of Anastomotic Leak in Colorectal Cancer Open Surgery. Dig Surg. 2018;35(1):77-84. DOI:10.1159/000456081
21. Walker PA, Kunjuraman B, Bartolo DCC. Neutrophil-to-lymphocyte ratio predicts anastomotic dehiscence. ANZ J Surg. 2018;88(9):939. DOI:10.1111/ans.14795.
22. Satomi A, Murakami S, Ishida K, Mastuki M, Hashimoto T, Sonoda M. Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol. 1995;34(1):69-73. DOI:10.3109/02841869509093641.
23. Li H, Zhao Y, Zheng F. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis. Medicine (Baltimore). 2019;98(3):e14126. DOI:10.1097/MD.0000000000014126.
24. Palin RP, Devine AT, Hicks G, Burke D. Association of pretreatment neutrophil-lymphocyte ratio and outcome in emergency colorectal cancer care. Ann R Coll Surg Engl. 2018;100(4):308–315. DOI:10.1308/rcsann.2017.0232
25. Cousin F, Ortega-Deballon P, Bourredjem A, Doussot A, Giaccaglia V, Fournel I. Diagnostic Accuracy of Procalcitonin and C-reactive Protein for the Early Diagnosis of Intra-abdominal Infection After Elective Colorectal Surgery. Ann Surg. 2016;264(2):252–6. DOI:10.1097/SLA.0000000000001545
Review
For citations:
Shelygin Yu.A., Sukhina M.A., Nabiev E.N., Ponomarenko A.A., Nagudov M.A., Moskalev A.I., Sushkov O.I., Achkasov S.I. NEUTROPHIL-TO-LYMPHOCYTE RATIO AS AN INFECTIOUS COMPLICATIONS BIOMARKER IN COLORECTAL SURGERY (own data, systematic review and meta-analysis). Koloproktologia. 2020;19(4):71-92. https://doi.org/10.33878/2073-7556-2020-19-4-71-92